Source: News Medical Life Sciences, June 2025
Melanoma is among the most aggressive and common cancers. Surgery, chemotherapy, and radiation therapy have been the mainstay of melanoma treatment, but they fail to control aggressive tumors, especially when resistance develops. A new study published in the journal Scientific Reports explored the effectiveness of combined bacteriophage-gene therapy in a mouse melanoma model.
Each year, there are more than 132,000 new melanoma cases globally. Research has uncovered much of the biology of the tumor, leading to the development of effective immunotherapies, including gene therapy and anti-cancer vaccines.